US Edition
First patient enrolled in continued access protocol trial of heart transplant technology - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
First patient enrolled in continued access protocol trial of heart transplant technology - Cardiovascular News
Xvivo has announced that the first patient has been enrolled as part of the continued access protocol (CAP) study for its heart technology, Xvivo Heart Assist Transport, in the USA. This CAP study follows the PRESERVE trial and allows for the enrolment of up to 60 patients across 26 US transplant centres. The study has received continued cost recovery approval from the Centers for Medicare & Medicaid Services (CMS), providing essential access an…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
